Issue 252
Welcome back to E&O: SaMD, a paying subscribers-only weekly newsletter focused on the world of digital pharma products, prescription digital therapeutics and other FDA-regulated digital health.
E&O: Software as a Medical Device
This week's newsletter includes an interesting round-up of recent changes to digital health-focused clinical trials as well as a few more pertinent details surrounding Whoop's regulatory spat with the FDA